Norstella news

Norstella’s AI bet: Clinical trials are often won or lost before the first patient enrolls

Somewhere in the world right now, a patient sits in a clinic waiting room ahead of a clinical trial visit. On the clipboard is eligibility status, recent labs, comorbidities, medication history, prior notes, all of it needing clinician review before anything else happens. This is…

Recursion expands strategic partnership with Citeline to advance its AI-enabled ClinTech platform

New York and Salt Lake City – Mar. 31, 2026 – Citeline, a leader in clinical solutions for the life sciences industry, today announced an expanded strategic partnership with Recursion (NASDAQ: RXRX), a leading tech-bio company decoding biology through advanced data science and automation….

Fred Hassan appointed Executive Chair of Norstella

New York, New York – Jan. 12, 2026 – Norstella, a leading global provider of pharma intelligence solutions, announced today that healthcare industry leader Fred Hassan has been appointed Executive Chair….

Norstella appoints Dan Tempesta as Chief Financial Officer

New York, New York – Sept. 9, 2025 – Norstella, a leading global provider of pharma intelligence solutions, has appointed Dan Tempesta as its new Chief Financial Officer. This marks an exciting milestone in Norstella’s journey and underscores the company’s commitment to its next phase…
Load more

Real-world data: Closing the strategy gap